Access the full text.
Sign up today, get DeepDyve free for 14 days.
E. Raetz, Marianne Kim, P. Moos, Marlee Carlson, C. Bruggers, David Hooper, Laura Foot, Tong Liu, R. Seeger, W. Carroll (2003)
Identification of genes that are regulated transcriptionally by Myc in childhood tumorsCancer, 98
Takeo Tanaka, D. Slamon, H. Shimoda, C. Waki, Y. Kawaguchi, Yoshito Tanaka, N. Ida (1988)
Expression of Ha-ras oncogene products in human neuroblastomas and the significant correlation with a patient's prognosis.Cancer research, 48 4
Christine Hacker, Ralf Kirsch, X. Ju, T. Hieronymus, T. Gust, Christiane Kuhl, Thorsten Jorgas, S. Kurz, S. Rose-John, Y. Yokota, M. Zenke (2003)
Transcriptional profiling identifies Id2 function in dendritic cell developmentNature Immunology, 4
H. Weintraub (1993)
The MyoD family and myogenesis: Redundancy, networks, and thresholdsCell, 75
T. Matsuo, P. Seth, C. Thiele (2001)
Increased expression of p27Kip1 arrests neuroblastoma cell growth.Medical and pediatric oncology, 36 1
A. Iavarone, P. Garg, A. Lasorella, J. Hsu, M. Israel (1994)
The helix-loop-helix protein Id-2 enhances cell proliferation and binds to the retinoblastoma protein.Genes & development, 8 11
K. Shigemasa, K. Shigemasa, C. Hu, C. Hu, C. West, C. West, J. Clarke, J. Clarke, G. Parham, G. Parham, T. Parmley, T. Parmley, S. Korourian, S. Korourian, Vicki Baker, Vicki Baker, O'Brien Tj, O'Brien Tj (1997)
p16 Overexpression: A Potential Early Indicator of Transformation in Ovarian CarcinomaJournal of the Society for Gynecologic Investigation, 4
J. Vandesompele, A. Edsjö, K. Preter, H. Axelson, F. Speleman, S. Påhlman (2003)
ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic valueOncogene, 22
R. Nho, R. Sheaff (2003)
p27kip1 contributions to cancer.Progress in cell cycle research, 5
R. Seeger, G. Brodeur, H. Sather, A. Dalton, S. Siegel, K. Wong, D. Hammond (1985)
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.The New England journal of medicine, 313 18
A. Jögi, I. Øra, Helén Nilsson, Åsa Lindeheim, Y. Makino, L. Poellinger, H. Axelson, S. Påhlman (2002)
Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotypeProceedings of the National Academy of Sciences of the United States of America, 99
A. Lasorella, M. Noseda, Mercedes Beyna, A. Iavarone (2000)
Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteinsNature, 407
M. Diccianni, M. Omura‐Minamisawa, A. Batova, T. Le, L. Bridgeman, A. Yu (1999)
Frequent deregulation of p16 and the p16/G1 cell cycle‐regulatory pathway in neuroblastomaInternational Journal of Cancer, 80
Ying Dong, M. Walsh, M. McGuckin, Brian Gabrielli, M. Cummings, R. Wright, T. Hurst, S. Khoo, P. Parsons (1997)
Increased expression of cyclin‐dependent kinase inhibitor 2 (CDKN2A) gene product P16 INK4A in ovarian cancer is associated with progression and unfavourable prognosisInternational Journal of Cancer, 74
C. Lee, P. Capodieci, I. Osman, M. Fazzari, J. Ferrara, H. Scher, C. Cordon-Cardo (1999)
Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer.Clinical cancer research : an official journal of the American Association for Cancer Research, 5 5
M. Kurabayashi, R. Jeyaseelan, L. Kedes (1993)
Two distinct cDNA sequences encoding the human helix-loop-helix protein Id2.Gene, 133 2
John Easton, T. Wei, J. Lahti, Vincent Kidd (1998)
Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.Cancer research, 58 12
A. Lasorella, A. Iavarone, M. Israel (1996)
Id2 specifically alters regulation of the cell cycle by tumor suppressor proteinsMolecular and Cellular Biology, 16
A. Sgambato, A. Cittadini, B. Faraglia, I. Weinstein (2000)
Multiple functions of p27Kip1 and its alterations in tumor cells: a reviewJournal of Cellular Physiology, 183
N. Kawamata, T. Seriu, H. Koeffler, C. Bartram (1996)
Molecular analysis of the cyclin‐dependent kinase inhibitor family: p16(CDKN2/MTS1/INK4A), p18(INK4C) and p27(Kip1) genes in neuroblastomasCancer, 77
K. Polyak, J. Kato, M. Solomon, C. Sherr, J. Massagué, James Roberts, A. Koff (1994)
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.Genes & development, 8 1
Y. Sato, Y. Kobayashi, H. Sasaki, T. Toyama, S. Kondo, M. Kiriyama, Y. Fujii (2003)
Expression of Id2 mRNA in neuroblastoma and normal ganglion.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 29 3
Xiao Sun, N. Copeland, N. Jenkins, D. Baltimore (1991)
Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helix proteinsMolecular and Cellular Biology, 11
Eckhard Bergmann, M. Wanzel, A. Weber, Inhee Shin, H. Christiansen, M. Eilers (2001)
Expression of P27KIP1 is prognostic and independent of MYCN amplification in human neuroblastomaInternational Journal of Cancer, 95
C. Beltinger, P. White, E. Sulman, J. Maris, G. Brodeur (1995)
No CDKN2 mutations in neuroblastomas.Cancer research, 55 10
C. Murre, P. McCaw, H. Vaessin, M. Caudy, L. Jan, Y. Jan, C. Cabrera, J. Buskin, S. Hauschka, A. Lassar, H. Weintraub, D. Baltimore (1989)
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequenceCell, 58
M. Diccianni, L. Chau, A. Batova, T. Vu, A. Yu (1996)
The p16 and p18 tumor suppressor genes in neuroblastoma: implications for drug resistance.Cancer letters, 104 2
Qun Wang, G. Hii, S. Shusterman, Y. Mossé, C. Winter, Chun Guo, Huaqing Zhao, E. Rappaport, M. Hogarty, J. Maris (2003)
ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.Cancer research, 63 7
T. Matsuo, C. Thiele (1998)
p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS–KCNR human neuroblastoma cell lineOncogene, 16
Jeannette Philipp-Staheli, Shannon Payne, C. Kemp (2001)
p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer.Experimental cell research, 264 1
A. Borriello, V. Pietra, M. Criscuolo, A. Oliva, G. Tonini, A. Iolascon, V. Zappia, F. Ragione (2000)
p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradationOncogene, 19
Akira Ishiguro, Konstantin Spirin, Masaaki Shiohara, Andreas Tobler, A. Gombart, Mark Israel, John Norton, H. Koeffler (1996)
Id2 expression increases with differentiation of human myeloid cells.Blood, 87 12
G. Viglietto, M. Motti, Alfredo Fresco (2002)
Understanding p27kip1 Deregulation in Cancer: Downregulation or Mislocalizaiton?Cell Cycle, 1
M. Omura‐Minamisawa, M. Diccianni, Ray Chang, A. Batova, L. Bridgeman, Jessica Schiff, S. Cohn, W. London, Alice Yu (2001)
p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.Clinical cancer research : an official journal of the American Association for Cancer Research, 7 11
O. Halvorsen, J. Hostmark, S. Haukaas, P. Høisaeter, L. Akslen (2000)
Prognostic significance of p16 and CDK4 proteins in localized prostate carcinoma.Cancer, 88 2
E. Olson, W. Klein (1994)
bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out.Genes & development, 8 1
C. Sherr (2004)
Principles of Tumor SuppressionCell, 116
J. Rocco, D. Sidransky (2001)
p16(MTS-1/CDKN2/INK4a) in cancer progression.Experimental cell research, 264 1
A. Lassar, R. Davis, W. Wright, T. Kadesch, C. Murre, A. Voronova, D. Baltimore, H. Weintraub (1991)
Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivoCell, 66
Thomas Ellenberger, Deborah Fass, Martha Arnaud, Stephen Harrison, Stephen Harrison (1994)
Crystal structure of transcription factor E47: E-box recognition by a basic region helix-loop-helix dimer.Genes & development, 8 8
G. Brodeur (2002)
Significance of intratumoral genetic heterogeneity in neuroblastomas.Medical and pediatric oncology, 38 2
C. Sherr, James Roberts (1999)
CDK inhibitors: positive and negative regulators of G1-phase progression.Genes & development, 13 12
O. Kranenburg, V. Scharnhorst, Van Eb, A. Zantema (1995)
Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cellsThe Journal of Cell Biology, 131
D. Jarrard, J. Modder, P. Fadden, Vivian Fu, L. Sebree, D. Heisey, S. Schwarze, A. Friedl (2002)
Alterations in the p16/pRb cell cycle checkpoint occur commonly in primary and metastatic human prostate cancer.Cancer letters, 185 2
D. Tweddle, A. Pearson, M. Haber, M. Norris, Chengyuan Xue, C. Flemming, J. Lunec (2003)
The p53 pathway and its inactivation in neuroblastoma.Cancer letters, 197 1-2
(2002)
P16 expression is not correlated with expression of Id2 or the loss of p27kip1 at protein level in advanced stage neuroblastoma (abstract)
R. Benezra, R. Davis, A. Lassar, S. Tapscott, M. Thayer, D. Lockshon, H. Weintraub (1990)
Id: A Negative Regulator of Helix‐Loop‐Helix DNA Binding ProteinsAnnals of the New York Academy of Sciences, 599
P. Knoepfler, P. Cheng, R. Eisenman (2002)
N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation.Genes & development, 16 20
M. Encinas, M. Iglesias, Yuhui Liu, Hongyin Wang, Ashraf Muhaisen, V. Ceña, C. Gallego, J. Comella (2000)
Sequential Treatment of SH‐SY5Y Cells with Retinoic Acid and Brain‐Derived Neurotrophic Factor Gives Rise to Fully Differentiated, Neurotrophic Factor‐Dependent, Human Neuron‐Like CellsJournal of Neurochemistry, 75
Y. Jan, L. Jan (1993)
HLH proteins, fly neurogenesis, and vertebrate myogenesisCell, 75
G. Brodeur, R. Seeger, R. Seeger, M. Schwab, H. Varmus, J. Bishop (1984)
Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.Science, 224 4653
A. Lasorella, R. Boldrini, C. Dominici, A. Donfrancesco, Y. Yokota, A. Inserra, A. Iavarone (2002)
Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma.Cancer research, 62 1
Lisong Shen, R. Tsuchida, Jun Miyauchi, Morihiro Saeki, Toshiro Honna, Yukiko Tsunematsu, Jun-ya Kato, Shuki Mizutani (2000)
Differentiation-associated expression and intracellular localization of cyclin-dependent kinase inhibitor p27KIP1 and c-Jun co-activator JAB1 in neuroblastoma.International journal of oncology, 17 4
Despite considerable research into the etiology of neuroblastoma, the molecular basis of this disease has remained elusive. In contrast to the absence of expression of the known tumor suppressor CDKN2A (also known as p16 and INK4A) in a wide variety of tumor types we have found in previous studies that CDKN2A protein is paradoxically highly expressed in many advanced stage neuroblastomas and unrelated to RB1 status. In the present study, we sought to identify the mechanistic relationships that might influence CDKN2A expression and negate its influence on tumor cell proliferation. In this regard, we examined the role of the tumor‐suppressor gene CDKN1B (also known as p27 and Kip1) and the oncogene ID2 in relationship to CDKN2A expression, MYCN amplification, and neuroblastoma pathogenesis in 17 neuroblastoma cell lines and 129 samples of primary tumors of all stages. All neuroblastoma cell lines expressed the ID2 transcript and protein. However, although the majority of primary neuroblastomas also expressed the ID2 transcript, expression of the ID2 protein was undetectable or only barely detectable, regardless of transcript expression. In both cell lines and primary tumors, ID2 expression was independent of both CDKN2A and MYCN expression. In primary neuroblastomas, CDKN1B protein was expressed in significantly fewer advanced‐stage neuroblastomas than early‐stage neuroblastomas, but its expression had no relationship with CDKN2A expression or MYCN amplification. We concluded that the paradoxical expression of CDKN2A in neuroblastoma cannot be explained by inactivation of the tumor‐suppressor gene CDKN1B or overexpression of the oncogene ID2. We further concluded that ID2 is not a target of MYCN regulation nor is it a prognostic factor for neuroblastoma. Finally, the loss of CDKN1B in advanced‐stage neuroblastoma suggests this protein may play a role in the neuroblastoma disease process. © 2004 Wiley‐Liss, Inc.
Genes, Chromosomes and Cancer – Wiley
Published: Dec 1, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.